ASCO 2020: Chemo within 3 months of COVID-19 diagnosis associated with an increased risk of death in patients with thoracic cancer
Among patients with lung and other thoracic cancers also diagnosed with COVID-19, prior use of…
Author ONA_Eloise
ONA_Eloise
Our Editorial Assistant and all round digital genius!
Blocking tumour signals can hinder cancer’s spread
For most people who die of cancer, the spread of the initial tumour is to…
ASCO 2020: Immunotherapy following chemotherapy offers extended survival to patients with advanced urothelial cancer
Treatment with avelumab combined with best supportive care following chemotherapy significantly extended overall survival compared…
ASCO 2020: Surgery and radiation do not extend survival in newly diagnosed metastatic breast cancer
Up to now, women who present with a new diagnosis of breast cancer that is…
ASCO 2020: Immunotherapy avelumab shows potential in rare gynaecological cancer resistant to chemotherapy
In a small, phase II study of a very rare cancer that develops inside a…
ASCO 2020: Multinational consortium reports COVID-19 impact on cancer patients
People with cancer sickened by COVID-19 have a crude death rate of 13%, according to…
ASCO 2020: Post-surgery osimertinib delays disease recurrence in patients with localised non-small cell lung cancer
Treatment with targeted therapy osimertinib following surgery for localised non-small cell lung cancer (NSCLC) with…
New drug combinations help overcome resistance to immunotherapy
A study from researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, helps explain how…
ASCO 2020: Early data show cancer progression associated with increased risk of death in patients with COVID-19
In patients with cancer and COVID-19, cancer that is progressing was independently associated with an…
ASCO 2020: Special report provides guidance to oncology practices on resuming cancer care during COVID-19 pandemic
The American Society of Clinical Oncology (ASCO) recently released the ASCO Special Report: A Guide…